Focus Partners Advisor Solutions’s Novo Nordisk NVO Stock Holding History

Focus Partners Advisor Solutions’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$350K	Sell	7,299 -74	-1%	-$3.18K	﹤0.01%	944
2026 Q1	$271K	Buy	7,373 +1,111	+18%	+$52.6K	﹤0.01%	1019
2025 Q4	$319K	Sell	6,262 -3,019	-33%	-$154K	﹤0.01%	871
2025 Q3	$447K	Buy	9,281 +1,963	+27%	+$115K	0.01%	770
2025 Q2	$504K	Buy	7,318 +1,024	+16%	+$69.7K	0.01%	668
2025 Q1	$437K	Buy	+6,294	New	+$520K	0.01%	631
2024 Q4	–	Sell	-5,404	Closed	-$644K	–	843
2024 Q3	$644K	Buy	5,404 +1,313	+32%	+$175K	0.01%	386
2024 Q2	$584K	Sell	4,091 -1,551	-27%	-$206K	0.02%	338
2024 Q1	$725K	Buy	5,642 +2,418	+75%	+$288K	0.02%	290
2023 Q4	$334K	Buy	+3,224	New	+$319K	0.02%	318

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Focus Partners Advisor Solutions's NVO Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its Novo Nordisk (NVO) stake by 1% in Q2 2026, selling an estimated $3.18K and leaving 7,299 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #944.

Focus Partners Advisor Solutions first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $725K in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Focus Partners Advisor Solutions held 7,299 shares of Novo Nordisk worth $350K as of Q2 2026.
Focus Partners Advisor Solutions sold 74 Novo Nordisk shares in Q2 2026, an estimated $3.18K.
Novo Nordisk made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #944 holding.
Focus Partners Advisor Solutions first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
Focus Partners Advisor Solutions's Novo Nordisk position peaked at $725K in Q1 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.